This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Love Right Now

Horizon Pharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another stock that insiders are finding attractive here is biotechnology and drugs player Horizon Pharma (HZNP), which develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Insiders are sniffing out some deep value here, since shares are down by a whopping 60% in the last three months. MP/>Horizon Pharma has a market cap of $107.44 million and an enterprise value of $100.17 million. This stock trades at a fair valuation, with a price-to-sales of 11.07 and a price-to-book of 1.94. Its estimated growth rate for this year is -22.7%, and for next year it's pegged at 48.3%. This is barley a cash-rich company, since the total cash position on its balance sheet is $63.46 million and its total debt is $51.12 million.

A director just bought 575,356 shares, or about $2 million worth of stock, at $3.49 per share.

From a technical perspective, HZNP is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock has been destroyed by the sellers during the last three months, with shares plunging from its high of $8.72 to its recent low of $3.15 a share.

During that sharp move lower, shares of HZNP have been consistently making lower highs and lower lows, which is bearish technical price action. This stock also recently gapped down from around $4.50 to $3.50 a share with heavy volume.

If you're in the bull camp on HZNP, then I would only look for long-biased trades if it can manage to break out above some near-term overhead resistance at $3.53 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.3 million shares. If we get that breakout soon, then HZNP could re-fill that gap from September that started near $4.50 a share.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs